Bootleg Liquor Deaths Spark Renewed Debate on Turkey’s Alcohol Tax

Bootleg Liquor Deaths Spark Renewed Debate on Turkey’s Alcohol Tax

Recent bootleg liquor deaths in Istanbul reignite discussions on Turkey’s high alcohol taxes and their impact on public safety Bootleg Liquor Deaths Spark Renewed Debate on Turkey’s Alcohol Tax Istanbul: Recently, 33 people died and 29 others ended up in intensive care after consuming bootleg liquor. This tragic event has put Turkey’s alcohol tax policies…

Calorie Labelling on Menus Shows Small Impact on Food Choices, Review Says

Calorie Labelling on Menus Shows Small Impact on Food Choices, Review Says

A recent review finds calorie labels have a small but meaningful effect on food choices, potentially aiding in healthier eating habits. Calorie Labelling on Menus Shows Small Impact on Food Choices, Review Says London: A new review has found that calorie labelling on menus and food products can lead to a small reduction in the…

Younger Workers Face Higher Burnout Rates Amid Growing Generation Gap

Younger Workers Face Higher Burnout Rates Amid Growing Generation Gap

A recent survey shows younger workers are struggling more with burnout than older colleagues Younger Workers Face Higher Burnout Rates Amid Growing Generation Gap London: A new report reveals that younger workers are feeling the heat more than their older counterparts. It turns out that about one in three workers aged 18-24 took time off…

US Appeals Court Allows Generic Version of Novartis’ Entresto to Launch

US Appeals Court Allows Generic Version of Novartis’ Entresto to Launch

A U.S. appeals court has lifted a temporary hold on MSN Pharmaceuticals’ generic Entresto, allowing its launch amid a patent dispute. US Appeals Court Allows Generic Version of Novartis’ Entresto to Launch Washington: So, here’s the scoop. MSN Pharmaceuticals just got the green light to launch its generic version of Entresto, a heart-failure drug from…

Gilead Sciences and US Government Reach Settlement on HIV Drug Patents

Gilead Sciences and US Government Reach Settlement on HIV Drug Patents

Gilead Sciences and the U.S. government have settled a major patent dispute over HIV prevention drugs Truvada and Descovy in Delaware. Gilead Sciences and US Government Reach Settlement on HIV Drug Patents Foster City: So, Gilead Sciences and the U.S. government just settled a big patent case over their HIV prevention drugs, Truvada and Descovy.…

US Bans Red Food Dye Linked to Cancer After Decades of Warnings

US Bans Red Food Dye Linked to Cancer After Decades of Warnings

The US has banned Red Dye No 3, a controversial additive linked to cancer, after years of scientific concerns US Bans Red Food Dye Linked to Cancer After Decades of Warnings New York: So, the US has finally decided to ban Red Dye No 3, which has been under fire for years. This dye has…

US Bans Red Food Dye Over Cancer Concerns, Health Authorities Announce

US Bans Red Food Dye Over Cancer Concerns, Health Authorities Announce

The US has banned Red Dye No 3 due to its potential cancer risks, following decades of health concerns. US Bans Red Food Dye Over Cancer Concerns, Health Authorities Announce Washington: So, the Biden administration just dropped a big one. They’ve banned Red Dye No 3, which has been linked to cancer in animals for…

Large Portions and Forcing Kids to Finish Meals May Fuel Obesity Crisis

Large Portions and Forcing Kids to Finish Meals May Fuel Obesity Crisis

A new study reveals that large food portions for kids could be contributing to rising obesity rates in Britain Large Portions and Forcing Kids to Finish Meals May Fuel Obesity Crisis London: A recent study highlights that big food portions for kids might be a key factor in the obesity crisis in Britain. Nutritionists are…

GSK to Acquire US Cancer Drug Firm IDRx for Up to .15 Billion

GSK to Acquire US Cancer Drug Firm IDRx for Up to $1.15 Billion

GSK is set to buy IDRx, a US cancer drug company, for up to $1.15 billion to enhance its oncology portfolio and address treatment gaps. GSK to Acquire US Cancer Drug Firm IDRx for Up to $1.15 Billion Plymouth: GSK, the UK’s second-largest drugmaker, is making a big move by acquiring IDRx, a company focused…

GSK Acquires US Rare Cancer Treatment Developer for Up to £1bn

GSK Acquires US Rare Cancer Treatment Developer for Up to £1bn

GSK is set to buy IDRx, a US firm focused on rare cancer therapies, for up to £1bn, aiming to enhance treatment options. GSK Acquires US Rare Cancer Treatment Developer for Up to £1bn Boston: GSK is making a big move by buying IDRx, a biopharmaceutical company in the US. They’re paying up to $1.15…